Chemists in the College of Arts and Sciences have figured out how to turn bacterial molecules into potential drug molecules.
Yan-Yeung Luk, associate professor of chemistry, and his research team have published their findings in ChemBioChem (John Wiley & Sons, 2015), explaining how they have created molecules that mimic and dominate toxic ones secreted by bacteria.
The implications for the study of biology and pharmacology are said to be enormous.
“Using toxic molecules to develop therapeutic agents, such as a vaccine, is not easy,” says Luk, who works at the interface of organic chemistry and the life sciences. “We’re just beginning to understand how some molecules—synthetic or naturally occurring—control the activities of bacteria. This will help us develop, among other things, drugs with many different applications.”
The Luk Research Group is focusing its attention on Pseudomonas aeruginosa, a microbe that causes many diseases and illnesses, including cystic fibrosis. Like other bacteria, P. aeruginosa produces a range of molecules that guides various activities. Among these molecules are rhamnolipids, which are made up of rhamnose sugar rings and fatty acids, and are able to reduce the surface tension of water. While rhamnolipids have been studied for decades, scientists don’t really know how they affect bacterial behavior.
Enter Luk, who, along with his research team, designs molecules that control such behavior. Their latest creation is a class of molecules called synthetic disaccharide derivatives (DSDs), which take over the chemical signaling of rhamnolipids to control activities such as biofilm formation, bacterial adhesion and swarming motility.
Lead author Nischal Singh G’15 and the rest of the Luk team have also discovered a subset of DSDs that dominates the function of rhamnolipids, and has demonstrated capacity for a range of new, unexpected bioactivities. The latter includes phenotypic switching, in which bacteria abandon their original phenotypes to “change” into two different phenotypes, and bacterial adhesion, considered the first step in colonization and biofilm formation.
“Biologists know how rhamnopilids are made by bacteria, and can knock out their production, but they don’t fully understand how rhamnolipids work—specifically, how they control different types of bacterial activities,” Luk says.
In addition to being non-toxic and biodegradable, rhamnolipids can withstand extreme temperatures, salinity and acidity. As a result, they have many useful chemical and biological properties.
Luk says that developing rhamnolipids into therapeutic agents has been speculated about for years, but without successful results. He hopes his group’s synthetic rhamnolipids approach is the exception. After designing and synthesizing two chemical libraries, or collections, of molecules, Luk’s third one contained two DSDs whose structures dominated the functions of rhamnolipids, offering the potential for many applications. It is from these two molecules that Luk’s team is making new ones.
The Latest on: Rhamnolipids
[google_news title=”” keyword=”Rhamnolipids” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Rhamnolipids
- Rhamnolipids Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2028on February 6, 2023 at 2:58 am
Feb 06, 2023 (The Expresswire) -- "Rhamnolipids Market" Size, Share and Trends Analysis Report 2023 - By Applications (Oil, Agricultural, Food, ...
- Microbial Biosurfactants Market by Top Countries Data, Key Players, with Industry Overview till 2023 to 2028on February 3, 2023 at 12:48 am
Microbial Biosurfactants Market report's in-depth analysis of the restraints shows how they different from drivers ...
- Holiferm and Sasol Chemicals Expand Collaboration to Develop and Market Sustainable Surfactantson January 26, 2023 at 7:51 am
Sophorolipids, rhamnolipids and MELs are all glycolipids made through fermentation, using yeast or bacteria to convert vegetable oils and/or sugars into final product. The Holiferm process offers ...
- Holiferm and Sasol Chemicals Expand Collaboration to Develop and Market Sustainable Surfactantson January 25, 2023 at 5:06 am
Holiferm Limited and Sasol Chemicals, a business unit of Sasol Ltd. (JSE: SOL; NYSE: SSL), announced today a collaboration to produce and market rhamnolipids and mannosylerythritol lipids (MELs).
- Holiferm and Sasol Chemicals Expand Collaboration to Develop and Market Sustainable Surfactantson January 25, 2023 at 5:03 am
Holiferm Limited and Sasol Chemicals, a business unit of Sasol Ltd. (JSE: SOL; NYSE: SSL), announced today a collaboration to produce and market rhamnolipids and mannosylerythritol lipids (MELs). This ...
- Sasol Limited (SOL.JO)on January 24, 2023 at 4:00 pm
HAMBURG, Germany, January 25, 2023--Holiferm Limited and Sasol Chemicals, a business unit of Sasol Ltd. (JSE: SOL; NYSE: SSL), announced today a collaboration to produce and market rhamnolipids ...
- Anticancer Activity of Rhamnolipids and Sophorolipids Biosurfactant Congenerson December 1, 2022 at 2:20 pm
Rhamnolipids and sophorolipids are glycolipidic biosurfactants produced by bacterial and yeast cells, respectively and possess both hydrophobic and hydrophilic moieties. Studies in our laboratory have ...
- Anticancer Activity of Rhamnolipids and Sophorolipids Biosurfactant Congenerson November 30, 2022 at 8:51 am
Prof Ibrahim Banat, Dr Matthew Twigg Monday, February 27, 2023 Competition Funded PhD Project (Students Worldwide) Based on your current searches we recommend the following search filters. Check out ...
- Examples of 'rhamnolipid' in a sentenceon May 4, 2022 at 4:46 pm
We welcome feedback: report an example sentence to the Collins team. Read more… Moreover, mutants deficient in rhamnolipids synthesis fail to maintain open channels, which are necessary for ...
- Rhamnolipid Marketon September 22, 2017 at 5:56 pm
Rhamnolipids are biosurfactants produced by various bacterial species. These bacterial surfactants are extensively used in industrial applications. They are majorly produced by pathogens called ...
via Bing News